Review
Open access
Jul 2026
Clinical significance and safety profile of antibody-drug conjugates in malignancies of the female reproductive system
The most clinically significant ADCs in gynecologic oncology are mirvetuximab soravtansine, tisotumab vedotin, and trastuzumab deruxtecan; promising data have also been identified for Trop-2- and cadherin-6-targeting conjugates.
D. M. Uzdenova, E. A. Timofeeva, D. M. Isaev et al.
· Obstetrics Gynecology and Re... · 1 citation